Author |
Year |
Totalpatients |
Overlappatients |
Prevalence |
Diagnosticcriteria† |
Boberg et al. [82] |
1996 |
114 with PSC |
2 definite
38 probable |
2%
33% |
Original scoring system |
Czaja [2] |
1998 |
162 with AIH |
0 |
0% |
Modified IAIHG scoring system |
26 with PSC |
14 |
54% |
Van Buuren et al. [76] |
2000 |
113 with PSC |
9 |
8% |
Descriptive |
9 definite
0 probable |
8% |
Original scoring system |
8 definite
1 probable |
7%
1% |
Revised scoring system |
Kaya et al. [81] |
2000 |
211 with PSC |
4 definite
40 probable |
2%
19% |
Original scoring system |
3 definite
13 probable |
1%
6% |
Revised scoring system |
Gheorghe et al. [48] |
2004 |
82 with AIH |
6 |
7% |
Revised scoring system/descriptive PSC |
Floreani et al. [90] |
2005 |
41 with PSC |
7 |
17% |
Revised scoring system/Descriptive PSCand ERCP |
Czaja [46] |
2008 |
24 with PSC |
2 definite
7 probable |
8%
29% |
Revised scoring system |
2 definite
3 probable |
8%
13% |
Simplified scoring system |
Chandok et al. [91] |
2010 |
147 with PSC |
0 definite
0 probable |
0% |
Revised scoring system |
0 definite
2 probable |
0%
1% |
Simplified scoring system |
Hunter et al. [92] |
2011 |
118 with AIH |
12* |
10% |
Descriptive AIH/PSC cholestasis andMRC |
Notes:* identified from 24 patients with cholestasis; †please see references for details on diagnostic criteria.